EC's disease prevention drive could boost sales
This article was originally published in Clinica
Executive Summary
The need to prevent disease rather than just treat illness is a priority for the EU, Health and Consumer Protection Commissioner David Byrne emphasised when he spoke at the European Policy Centre in Brussels on July 15. This high-level statement is good news for the IVD and medical device industries, since many of their technologies are aimed at preventing, rather than merely curing, disease.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.